BOSULIF - 0069-0135-01 - (Bosutinib monohydrate)

Alphabetical Index


Drug Information of BOSULIF

Product NDC: 0069-0135
Proprietary Name: BOSULIF
Non Proprietary Name: Bosutinib monohydrate
Active Ingredient(s): 100    mg/1 & nbsp;   Bosutinib monohydrate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of BOSULIF

Product NDC: 0069-0135
Labeler Name: Pfizer Laboratories Div Pfizer Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA203341
Marketing Category: NDA
Start Marketing Date: 20120904

Package Information of BOSULIF

Package NDC: 0069-0135-01
Package Description: 120 TABLET, FILM COATED in 1 BOTTLE (0069-0135-01)

NDC Information of BOSULIF

NDC Code 0069-0135-01
Proprietary Name BOSULIF
Package Description 120 TABLET, FILM COATED in 1 BOTTLE (0069-0135-01)
Product NDC 0069-0135
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Bosutinib monohydrate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120904
Marketing Category Name NDA
Labeler Name Pfizer Laboratories Div Pfizer Inc
Substance Name BOSUTINIB MONOHYDRATE
Strength Number 100
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]

Complete Information of BOSULIF


General Information